Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

NCT02013544 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

558

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaginal Atrophy

Interventions

DRUG: Placebo
DRUG: Prasterone (DHEA)

Sponsor

EndoCeutics Inc.